| Diana Desai, MD | |
|
500 University Dr, Hershey, PA 17033-2360 | |
| (800) 243-1455 | |
| Not Available |
| Full Name | Diana Desai |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | 500 University Dr, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124319876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0006X | Pathology - Clinical Pathology | MD455275 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Staten Island University Hospital | Staten island, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.
Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice.
A newly identified "metabolic signature" can evaluate an individual's adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain.
In North Carolina, the nation's leading tobacco producer, any adult who has smoked more than 100 cigarettes in their lifetime can now be vaccinated against Covid.
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company's investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer's disease.
› Verified 6 days ago
| Entity Name | Physicians Of University Hospital Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417901323 PECOS PAC ID: 5890877542 Enrollment ID: O20080204000002 |
News Archive
Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.
Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice.
A newly identified "metabolic signature" can evaluate an individual's adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain.
In North Carolina, the nation's leading tobacco producer, any adult who has smoked more than 100 cigarettes in their lifetime can now be vaccinated against Covid.
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company's investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer's disease.
› Verified 6 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.
Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice.
A newly identified "metabolic signature" can evaluate an individual's adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain.
In North Carolina, the nation's leading tobacco producer, any adult who has smoked more than 100 cigarettes in their lifetime can now be vaccinated against Covid.
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company's investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana Desai, MD Po Box 858, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Diana Desai, MD 500 University Dr, Hershey, PA 17033-2360 Ph: (800) 243-1455 |
News Archive
Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.
Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice.
A newly identified "metabolic signature" can evaluate an individual's adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain.
In North Carolina, the nation's leading tobacco producer, any adult who has smoked more than 100 cigarettes in their lifetime can now be vaccinated against Covid.
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company's investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer's disease.
› Verified 6 days ago
Dr. Hiroko Shike, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey Medical Center, Hershey, PA 17033 Phone: 717-531-8615 Fax: 717-531-3803 | |
Dr. Edward Eisenhower, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Erik Robert Washburn, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8246 Fax: 717-531-7741 | |
Jeannie Hennessy, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, H088, Hershey, PA 17033 Phone: 717-531-1692 | |
Evelyn Mary Potochny, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Mc A410, Hershey, PA 17033 Phone: 717-531-8615 Fax: 717-531-3803 | |
Dr. Eric Lipinsky Cochran, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8246 Fax: 717-531-7741 | |
Javad Towfighi, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 |